HR Execs on the Move

Tscan

www.tscan.com

 
TScan is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company’s lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tscan.com
  • 830 Winter Street
    Waltham, MA USA 02451
  • Phone: 857.399.9500

Executives

Name Title Contact Details
Brian Silver
 Chief Financial Officer Profile
Leiden Dworak
 Vice President, Finance Profile
David Southwell
 Chief Executive Officer Profile

Similar Companies

Kereos Inc

Kereos Inc is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Novara Tesija Michela and Priehs

Novara Tesija Michela and Priehs is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kiniciti

Empowering the industry with the resources, expertise, and capital to help accelerate the advancement and adoption of cell and gene therapies.

ILiAD Biotechnologies

ILiAD Biotechnologies, LLC manufactures vaccines for the prevention and treatment of disease caused by Bordetella Pertussis.

Arisaph Pharmaceuticals

Arisaph Pharmaceuticals is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.